Back to Search
MONTE MERRELL, M.D.
M.D.
General Practice Physician
NPI: 1295900165IndividualAccepts Medicare
Specialties, Licenses & Credentials
Obstetrics & Gynecology Physician
Obstetrics & Gynecology
Code: 207V00000X
107866(MN)
General Practice PhysicianPrimary
General Practice
Code: 208D00000X
58018(AZ)
CMS Specialties
PrimaryOBSTETRICS/GYNECOLOGY
Education
CREIGHTON UNIVERSITY SCHOOL OF MEDICINE
Class of 2005
Research & Publications (18)
The Nrf2 activator oltipraz also activates the constitutive androstane receptor.
PMID 18474683·Drug Metab Dispos·2008
7-preclinical
Evaluation of a new ELISA kit for the detection of benzodiazepines in meconium.
PMID 19371469·J Anal Toxicol·2009
4-observational
Comparison of drugs of abuse detection in meconium by EMIT II and ELISA.
PMID 19371463·J Anal Toxicol·2009
4-observational
Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion.
PMID 18922969·Mol Cancer Res·2008
7-preclinical
Quantitation of benzodiazepines in urine, serum, plasma, and meconium by LC-MS-MS.
PMID 18713517·J Anal Toxicol·2008
8-other
Inhibition of the mevalonate pathway and activation of p38 MAP kinase are independently regulated by nitrogen-containing bisphosphonates in breast cancer cells.
PMID 17640631·Eur J Pharmacol·2007
8-other
Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro.
PMID 17373717·Prostate·2007
8-other
Differential effects of Ca(2+) on bisphosphonate-induced growth inhibition in breast cancer and mesothelioma cells.
PMID 17214981·Eur J Pharmacol·2007
8-other
Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity.
PMID 16849519·Mol Cancer Res·2006
8-other
Bisphosphonates inhibit the growth of mesothelioma cells in vitro and in vivo.
PMID 16675582·Clin Cancer Res·2006
7-preclinical
Breast cancer cells with inhibition of p38alpha have decreased MMP-9 activity and exhibit decreased bone metastasis in mice.
PMID 15679050·Clin Exp Metastasis·2004
7-preclinical
Inhibition of gp130 signaling in breast cancer blocks constitutive activation of Stat3 and inhibits in vivo malignancy.
PMID 15466183·Cancer Res·2004
7-preclinical
Interleukin (IL)-15 and IL-2 reciprocally regulate expression of the chemokine receptor CX3CR1 through selective NFAT1- and NFAT2-dependent mechanisms.
PMID 15347678·J Biol Chem·2004
7-preclinical
Bisphosphonate induced growth inhibition of breast cancer cells is augmented by p38 inhibition.
PMID 14620918·Breast Cancer Res Treat·2003
4-observational
Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans.
PMID 12697743·J Clin Invest·2003
8-other
Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C.
PMID 12557141·Gastroenterology·2003
8-other
Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis.
PMID 11532900·Circ Res·2001
8-other
Periurethral vaginal adenocarcinoma of the intestinal type: report of two cases and review of the literature.
PMID 10831365·Gynecol Oncol·2000
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 300 W. WHITE MOUNTAIN BLVD. SUITE D
LAKESIDE, AZ 85929 - Phone
- (928) 368-4547
Quick Facts
- NPI
- 1295900165
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 21
- Publications
- 18
Are you this provider?
Claim Your Profile